Mineralys Therapeutics, Inc. (MLYS) SEC filings
MLYS SEC filings moved a median of +0.58% by the close. MLYS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MLYS overview →
68 measured MLYS SEC filing events.
Where these MLYS SEC filings landedvs 67 measured MLYS SEC filing reactions
| Middle 50% of MLYS SEC filing reactions | -1.14% to +3.58% |
|---|---|
| Median reaction (to close) | +0.58% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 MLYS SEC filing events with a measured close landed between -1.14% and +3.58%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Mineralys Therapeutics, For: Oct 16 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Mineralys Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.40% | +7.68% | |
| Form 8-K Mineralys Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +4.40% | +7.68% | |
| Form 8-K Mineralys Therapeutics, For: Jun 02 | SEC filing · Form 8-K | -1.59% | -5.36% | |
| Form 8-K Mineralys Therapeutics, For: Jun 03 | SEC filing · Form 8-K | +2.78% | -0.40% | |
| Form 8-K Mineralys Therapeutics, For: May 21 | SEC filing · Form 8-K | +1.49% | -0.76% | |
| Form 10-Q Mineralys Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.27% | +0.58% | |
| Form 8-K Mineralys Therapeutics, For: May 06 | SEC filing · Form 8-K | -0.27% | +0.58% | |
| Form ARS Mineralys Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.68% | +2.57% | |
| Form DEF 14A Mineralys Therapeutics, For: May 21 | SEC filing · Form DEF | -0.59% | -3.98% | |
| Form DEFA14A Mineralys Therapeutics, | SEC filing · Form DEFA14A | -0.59% | -3.98% | |
| Form 10-K Mineralys Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.53% | +1.47% | |
| Form 8-K Mineralys Therapeutics, For: Mar 12 | SEC filing · Form 8-K | +4.53% | +1.47% | |
| Form 8-K Mineralys Therapeutics, For: Mar 06 | SEC filing · Form 8-K | -0.04% | +7.49% | |
| Form S-8 Mineralys Therapeutics, | SEC filing · Form S-8 | +0.77% | +0.99% | |
| Form 8-K Mineralys Therapeutics, For: Jan 06 | SEC filing · Form 8-K | -0.39% | +0.51% | |
| Form 10-Q Mineralys Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.11% | +12.17% | |
| Form 8-K Mineralys Therapeutics, For: Nov 10 | SEC filing · Form 8-K | +1.11% | +12.17% | |
| Form S-3ASR Mineralys Therapeutics, | SEC filing · Form S-3ASR | +1.11% | +12.17% | |
| Form 8-K Mineralys Therapeutics, For: Sep 02 | SEC filing · Form 8-K | +0.48% | +12.54% | |
| Form 8-K Mineralys Therapeutics, For: Sep 02 | SEC filing · Form 8-K | +0.50% | +4.46% | |
| Form S-3MEF Mineralys Therapeutics, | SEC filing · Form S-3MEF | +0.50% | +4.46% | |
| Form 10-Q Mineralys Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.09% | +3.43% | |
| Form 8-K Mineralys Therapeutics, For: Aug 12 | SEC filing · Form 8-K | -0.09% | +3.43% | |
| Form 8-K Mineralys Therapeutics, For: Jun 17 | SEC filing · Form 8-K | -0.66% | +0.58% | |
| Form 8-K Mineralys Therapeutics, For: May 22 | SEC filing · Form 8-K | +1.22% | -0.13% | |
| Form 10-Q Mineralys Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.97% | +1.27% | |
| Form 8-K Mineralys Therapeutics, For: May 12 | SEC filing · Form 8-K | -0.97% | +1.27% | |
| Form ARS Mineralys Therapeutics, For: Dec 31 | SEC filing · Form ARS | -2.71% | +12.35% | |
| Form DEF 14A Mineralys Therapeutics, For: May 22 | SEC filing · Form DEF | -2.71% | +12.35% | |
| Form DEFA14A Mineralys Therapeutics, | SEC filing · Form DEFA14A | -2.71% | +12.35% | |
| Form 8-K Mineralys Therapeutics, For: Mar 29 | SEC filing · Form 8-K | -0.48% | +8.84% | |
| Form 8-K Mineralys Therapeutics, For: Mar 11 | SEC filing · Form 8-K | +1.57% | +3.61% | |
| Form 8-K Mineralys Therapeutics, For: Mar 10 | SEC filing · Form 8-K | -3.64% | +5.87% | |
| Form S-8 Mineralys Therapeutics, | SEC filing · Form S-8 | +0.00% | +2.30% | |
| Form 10-K Mineralys Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.50% | +0.19% | |
| Form 8-K Mineralys Therapeutics, For: Feb 12 | SEC filing · Form 8-K | -6.50% | +0.19% | |
| Form 8-K Mineralys Therapeutics, For: Feb 04 | SEC filing · Form 8-K | +2.94% | +3.55% | |
| Form 8-K Mineralys Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +0.94% | -12.57% | |
| Form 10-Q Mineralys Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.22% | -0.96% | |
| Form 8-K Mineralys Therapeutics, For: Nov 11 | SEC filing · Form 8-K | +0.22% | -0.96% | |
| Form S-8 Mineralys Therapeutics, | SEC filing · Form S-8 | -1.25% | -7.85% | |
| Form 8-K Mineralys Therapeutics, For: Oct 30 | SEC filing · Form 8-K | +0.29% | -0.07% | |
| Form 8-K Mineralys Therapeutics, For: Sep 25 | SEC filing · Form 8-K | +0.00% | +1.28% | |
| Form 10-Q Mineralys Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.43% | -18.19% | |
| Form 8-K Mineralys Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -1.43% | -18.19% | |
| Form 8-K Mineralys Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +0.00% | +1.53% | |
| Form 8-K Mineralys Therapeutics, For: Jun 10 | SEC filing · Form 8-K | -0.15% | -1.29% | |
| Form 8-K Mineralys Therapeutics, For: May 31 | SEC filing · Form 8-K | +2.11% | +0.54% | |
| Form 8-K Mineralys Therapeutics, For: May 22 | SEC filing · Form 8-K | -5.97% | -2.55% | |
| Form 10-Q Mineralys Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.24% | -2.79% | |
| Form 8-K Mineralys Therapeutics, For: May 09 | SEC filing · Form 8-K | -0.24% | -2.79% | |
| Form EFFECT Mineralys Therapeutics, | SEC filing · Form EFFECT | +1.46% | -0.15% | |
| Form ARS Mineralys Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.21% | -0.98% | |
| Form DEF 14A Mineralys Therapeutics, For: Apr 09 | SEC filing · Form DEF | -1.21% | -0.98% | |
| Form DEFA14A Mineralys Therapeutics, | SEC filing · Form DEFA14A | -1.21% | -0.98% | |
| Form 8-K Mineralys Therapeutics, For: Mar 29 | SEC filing · Form 8-K | +0.00% | -2.32% | |
| Form S-3/A Mineralys Therapeutics, | SEC filing · Form S-3 | +0.62% | +0.93% | |
| Form 10-K Mineralys Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.70% | -1.95% | |
| Form 8-K Mineralys Therapeutics, For: Mar 21 | SEC filing · Form 8-K | +2.70% | -1.95% | |
| Form S-3 Mineralys Therapeutics, | SEC filing · Form S-3 | +2.70% | -1.95% | |
| Form 8-K Mineralys Therapeutics, For: Feb 07 | SEC filing · Form 8-K | -0.71% | +4.10% | |
| Form 8-K Mineralys Therapeutics, For: Jan 04 | SEC filing · Form 8-K | -0.69% | -0.80% | |
| Form 8-K Mineralys Therapeutics, For: Dec 21 | SEC filing · Form 8-K | +3.01% | +6.03% | |
| Form 8-K Mineralys Therapeutics, For: Nov 11 | SEC filing · Form 8-K | -2.49% | -0.94% | |
| Form 10-Q Mineralys Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.69% | -6.74% | |
| Form 8-K Mineralys Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.69% | -6.74% | |
| Form 8-K Mineralys Therapeutics, For: Nov 02 | SEC filing · Form 8-K | +0.90% | +0.65% |
Keep exploring
More MLYS: earnings → · analyst actions → · MLYS overview →